Literature DB >> 33617602

Effector memory CD8 T cell response elicits Hepatitis E Virus genotype 3 pathogenesis in the elderly.

Hicham El Costa1,2, Jordi Gouilly1, Florence Abravanel1,2, Elmostafa Bahraoui1, Jean-Marie Peron3, Nassim Kamar1, Nabila Jabrane-Ferrat1, Jacques Izopet1,2.   

Abstract

Genotype 3 Hepatitis E virus (HEV-3) is an emerging threat for aging population. More than one third of older infected patients develops clinical symptoms with severe liver damage, while others remain asymptomatic. The origin of this discrepancy is still elusive although HEV-3 pathogenesis appears to be immune-mediated. Therefore, we investigated the role of CD8 T cells in the outcome of the infection in immunocompetent elderly subjects. We enrolled twenty two HEV-3-infected patients displaying similar viral determinants and fifteen healthy donors. Among the infected group, sixteen patients experienced clinical symptoms related to liver disease while six remained asymptomatic. Here we report that symptomatic infection is characterized by an expansion of highly activated effector memory CD8 T (EM) cells, regardless of antigen specificity. This robust activation is associated with key features of early T cell exhaustion including a loss in polyfunctional type-1 cytokine production and partial commitment to type-2 cells. In addition, we show that bystander activation of EM cells seems to be dependent on the inflammatory cytokines IL-15 and IL-18, and is supported by an upregulation of the activating receptor NKG2D and an exuberant expression of T-Bet and T-Bet-regulated genes including granzyme B and CXCR3. We also show that the inflammatory chemokines CXCL9-10 are increased in symptomatic patients thereby fostering the recruitment of highly cytotoxic EM cells into the liver in a CXCR3-dependent manner. Finally, we find that the EM-biased immune response returns to homeostasis following viral clearance and disease resolution, further linking the EM cells response to viral burden. Conversely, asymptomatic patients are endowed with low-to-moderate EM cell response. In summary, our findings define immune correlates that contribute to HEV-3 pathogenesis and emphasize the central role of EM cells in governing the outcome of the infection.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33617602      PMCID: PMC7932504          DOI: 10.1371/journal.ppat.1009367

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  64 in total

Review 1.  Age-related changes in immune function: effect on airway inflammation.

Authors:  Paula J Busse; Sameer K Mathur
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

2.  Genotype 3 diversity and quantification of hepatitis E virus RNA.

Authors:  Florence Abravanel; Karine Sandres-Saune; Sebastien Lhomme; Martine Dubois; Jean-Michel Mansuy; Jacques Izopet
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

Review 3.  Hepatitis E virus infection.

Authors:  Nassim Kamar; Harry R Dalton; Florence Abravanel; Jacques Izopet
Journal:  Clin Microbiol Rev       Date:  2014-01       Impact factor: 26.132

4.  Autochthonous hepatitis E in southwest England.

Authors:  H R Dalton; P H Thurairajah; H J Fellows; H S Hussaini; J Mitchell; R Bendall; M Banks; S Ijaz; C-G Teo; D F Levine
Journal:  J Viral Hepat       Date:  2007-05       Impact factor: 3.728

5.  Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.

Authors:  E John Wherry; Joseph N Blattman; Kaja Murali-Krishna; Robbert van der Most; Rafi Ahmed
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

7.  Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.

Authors:  Anthony Brown; John S Halliday; Leo Swadling; Richie G Madden; Richard Bendall; Jeremy G Hunter; James Maggs; Peter Simmonds; Donald B Smith; Louisa Vine; Cara McLaughlin; Jane Collier; David Bonsall; Katie Jeffery; Susanna Dunachie; Paul Klenerman; Jacques Izopet; Nassim Kamar; Harry R Dalton; Eleanor Barnes
Journal:  Hepatology       Date:  2016-10-28       Impact factor: 17.425

8.  Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy.

Authors:  Chai Fen Soon; Shihong Zhang; Pothakamuri Venkata Suneetha; Dinler Amaral Antunes; Michael Peter Manns; Solaiman Raha; Christian Schultze-Florey; Immo Prinz; Heiner Wedemeyer; Margaret Sällberg Chen; Markus Cornberg
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

9.  Immune dissociation during acute hepatitis E infection.

Authors:  Jose D Debes; Zwier M A Groothuismink; Michail Doukas; Robert A de Man; Andre Boonstra
Journal:  Int J Infect Dis       Date:  2019-08-10       Impact factor: 3.623

Review 10.  The activation of bystander CD8+ T cells and their roles in viral infection.

Authors:  Tae-Shin Kim; Eui-Cheol Shin
Journal:  Exp Mol Med       Date:  2019-12-11       Impact factor: 8.718

View more
  5 in total

Review 1.  Review of clinical characteristics, immune responses and regulatory mechanisms of hepatitis E-associated liver failure.

Authors:  Chong Chen; Shu-Ye Zhang; Liang Chen
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

2.  Assessment of hepatitis E seropositivity among HIV-infected patients in Bulgaria.

Authors:  Elitsa Golkocheva-Markova; Ani Kevorkyan; Ralitsa Raycheva; Chiydem Ismailova; Viliana Yoncheva; Tencho Tenev; Radoslava Emilova; Lyubomira Grigorova; Ivan Baltadzhiev; Radka Komitova
Journal:  Braz J Infect Dis       Date:  2022-02-15       Impact factor: 3.257

3.  The pivotal role of CD8+ T cells in hepatitis E virus infection.

Authors:  Yannick Brüggemann; Mara Klöhn; Daniel Todt
Journal:  J Hepatol       Date:  2022-08-14       Impact factor: 30.083

Review 4.  Mechanisms of Hepatocellular Injury in Hepatitis A.

Authors:  Minghang Wang; Zongdi Feng
Journal:  Viruses       Date:  2021-05-08       Impact factor: 5.048

Review 5.  Hepatitis E Virus Immunopathogenesis.

Authors:  Kush Kumar Yadav; Scott P Kenney
Journal:  Pathogens       Date:  2021-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.